Meeting NewsVideo

VIDEO: SightGlass Vision details development of spectacles for myopia control

ORLANDO, Fla. – SightGlass Vision chief medical officer, Joe Rappon, OD, MS, FAAO, traced the development of the company’s spectacle lens technology to control myopia progression in a poster here at the American Academy of Optometry meeting and World Congress of Optometry.

One-year results of the CYPRESS study, which is evaluating the safety and efficacy of the SightGlass product vs. standard spectacle lenses are expected in the second quarter of 2020, Rappon said.

Disclosure: Rappon is employed by SightGlass Vision.

ORLANDO, Fla. – SightGlass Vision chief medical officer, Joe Rappon, OD, MS, FAAO, traced the development of the company’s spectacle lens technology to control myopia progression in a poster here at the American Academy of Optometry meeting and World Congress of Optometry.

One-year results of the CYPRESS study, which is evaluating the safety and efficacy of the SightGlass product vs. standard spectacle lenses are expected in the second quarter of 2020, Rappon said.

Disclosure: Rappon is employed by SightGlass Vision.

    See more from American Academy of Optometry